Key Highlights
- Shares of AST SpaceMobile experienced an approximately 11% surge Thursday following confirmation that three additional BlueBird satellites will deploy in August using SpaceX’s Falcon 9 rocket.
- The updated deployment timeline positions the company to launch satellites bimonthly, achieving an annual rate of 18 satellites.
- Twenty-four satellites (BlueBirds 14-37) are presently in production, with orbital deployment targeted for completion by late 2027.
- Institutional ownership comprises approximately 61% of shares; company insiders have divested stock valued at more than $280 million over the past three months.
- Wall Street analysts maintain an average “Reduce” stance on the stock with a consensus target price of $85.09; Monday’s opening price was $71.57.
AST SpaceMobile (ASTS) experienced an approximate 11% gain Thursday, touching $71.58, though no immediate news catalyst emerged that day — the rally followed the company’s recent disclosure of an intensified satellite deployment schedule that energized market participants.
Earlier this week, the company announced that BlueBird satellites 11, 12, and 13 are scheduled for an August launch utilizing a SpaceX Falcon 9 vehicle. This deployment follows the June 17 successful launch of BlueBirds 8, 9, and 10.
The consecutive launches establish a deployment rhythm of approximately one mission bimonthly, yielding a potential yearly output of 18 satellites.
AST is presently manufacturing 24 satellites — BlueBirds 14 through 37. Maintaining the current tempo, these units should achieve orbit by 2027’s conclusion, coinciding with the planned beta service initiation for its direct-to-cell (DTC) infrastructure.
A European component also emerged. Discussions connected to a Vodafone-supported deployment identified Spain as a prospective early commercial territory, with service potentially beginning in 2027 — strengthening the international revenue narrative.
Wall Street’s Assessment and Target Prices
Despite share price momentum, analyst sentiment remains tepid to cautious. The consensus analyst rating for ASTS registers as “Reduce,” with an average target price of $85.09.
Deutsche Bank recently downgraded its stance from buy to hold, simultaneously reducing its target from $117 to $106. B. Riley shifted to “neutral” accompanied by an $85 valuation. Roth MKM represents one of the more optimistic perspectives, maintaining a “buy” recommendation with a $108 target.
Among ten tracked analysts, just one maintains a buy rating. Six recommend hold. Three advise sell.
The stock’s 50-day moving average sits at $87.18, while the 200-day average registers at $89.23 — both substantially exceeding current price levels.
Notable Insider Divestment Activity
A pattern that warrants attention: company insiders have engaged in substantial selling.
Throughout the preceding 90 days, insiders liquidated over 3.1 million shares valued at approximately $280.6 million. CFO Andrew Martin Johnson sold 45,809 shares at an average price of $93.81 on June 11, diminishing his holdings by 8.34%.
Director Julio A. Torres similarly divested 15,000 shares at $76.34 in May, trimming his position by roughly 26%.
Insider ownership currently represents 20.89% of outstanding shares, while institutional investors control 60.95%.
SG Americas Securities LLC expanded its ASTS position by 18.6% during Q1, acquiring 11,813 shares to reach a total holding of 75,157.
Regarding financial performance, AST’s first-quarter results disappointed. The company reported EPS of -$0.66, falling short of the -$0.23 consensus estimate. Revenue reached $14.73 million versus expectations of $39.01 million.
Analysts project full-year EPS of -$1.47. The stock’s 52-week trading range spans from $36.08 to $133.86.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
